FTC Thinks Rules Don't Apply To It: Watson CEO

Law360, New York (July 26, 2010, 6:31 PM EDT) -- Watson Pharmaceuticals Inc. CEO Paul M. Bisaro railed against the Federal Trade Commission on Monday, saying the agency has flouted the law while trying to force him to testify in a competition probe triggered by a patent settlement over the narcolepsy treatment Provigil.

There has been an unmistakable pattern to the FTC’s conduct in this case, including misleading counsel about the date of the filing of the action, attempting to lodge an improper surreply and engaging in an improper ex-parte communication with a judge's chambers, Bisaro...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.